Literature DB >> 9079636

Characterization of ligand binding of a soluble human insulin-like growth factor I receptor variant suggests a ligand-induced conformational change.

M Jansson1, D Hallén, H Koho, G Andersson, L Berghard, J Heidrich, E Nyberg, M Uhlén, J Kördel, B Nilsson.   

Abstract

Details of the signal transduction mechanisms of the tyrosine kinase family of growth factor receptors remain elusive. In this work, we describe an extensive study of kinetic and thermodynamic aspects of growth factor binding to a soluble extracellular human insulin-like growth factor-I receptor (sIGF-IR) variant. The extracellular receptor domains were produced fused to an IgG-binding protein domain (Z) in transfected human 293 cells as a correctly processed secreted alpha-beta'-Z dimer. The receptor was purified using IgG affinity chromatography, rendering a pure and homogenous protein in yields from 1 to 5 mg/liter of conditioned cell media. Biosensor technology (BIAcore) was applied to measure the insulin-like growth factor-I (IGF-I), des(1-3)IGF-I, insulin-like growth factor-II, and insulin ligand binding rate constants to the immobilized IGF-IR-Z. The association equilibrium constant, Ka, for the IGF-I interaction is determined to 2.8 x 10(8) M-1 (25 degrees C). Microcalorimetric titrations on IGF-I/IGF-IR-Z were performed at three different temperatures (15, 25, and 37 degrees C) and in two different buffer systems at 25 degrees C. From these measurements, equilibrium constants for the 1:1 (IGF-I:(alpha-beta'-Z)2) receptor complex in solution are deduced to 0.96 x 10(8) M-1 (25 degrees C). The determined heat capacity change for the process is large and negative, -0.51 kcal (K mol)-1. Further, the entropy change (DeltaS) at 25 degrees C is large and negative. Far- and near-UV circular dichroism measurements display significant changes over the entire wavelength range upon binding of IGF-I to IGF-IR-Z. These data are all consistent with a significant change in structure of the system upon IGF-I binding.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9079636     DOI: 10.1074/jbc.272.13.8189

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Thermodynamics-based drug design: strategies for inhibiting protein-protein interactions.

Authors:  Arne Schön; Sonia Y Lam; Ernesto Freire
Journal:  Future Med Chem       Date:  2011-07       Impact factor: 3.808

Review 2.  Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach.

Authors:  Rongshi Li; Alan Pourpak; Stephan W Morris
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

3.  Autologous bone marrow stromal cells genetically engineered to secrete an igf-I receptor decoy prevent the growth of liver metastases.

Authors:  Ni Wang; Lucia Fallavollita; Long Nguyen; Julia Burnier; Moutih Rafei; Jacques Galipeau; Shoshana Yakar; Pnina Brodt
Journal:  Mol Ther       Date:  2009-04-14       Impact factor: 11.454

4.  Dynamic microfunnel culture enhances mouse embryo development and pregnancy rates.

Authors:  Y S Heo; L M Cabrera; C L Bormann; C T Shah; S Takayama; G D Smith
Journal:  Hum Reprod       Date:  2010-01-03       Impact factor: 6.918

5.  Characterization of inhibitory anti-insulin-like growth factor receptor antibodies with different epitope specificity and ligand-blocking properties: implications for mechanism of action in vivo.

Authors:  Adam Doern; Xianjun Cao; Arlene Sereno; Christopher L Reyes; Angelina Altshuler; Flora Huang; Cathy Hession; Albert Flavier; Michael Favis; Hon Tran; Eric Ailor; Melissa Levesque; Tracey Murphy; Lisa Berquist; Susan Tamraz; Tracey Snipas; Ellen Garber; William S Shestowsky; Rachel Rennard; Christilyn P Graff; Xiufeng Wu; William Snyder; Lindsay Cole; David Gregson; Michael Shields; Steffan N Ho; Mitchell E Reff; Scott M Glaser; Jianying Dong; Stephen J Demarest; Kandasamy Hariharan
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

6.  Zinc alters the kinetics of IGF-II binding to cell surface receptors and binding proteins.

Authors:  Robert H McCusker; Rebecca L Mateski; Jan Novakofski
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.